PregLem SA

Also on record

Records under this name other than patents PregLem SA holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 7 of 7 · Back to PregLem SA

Patent	Title	Status	Expires	Confidence
US 9,168,264	Treatment of excessive menstrual bleeding associated with uterine fibroids Lapsed on the fee record Ended Oct 27, 2023 · From the USPTO record	Lapsed on the fee record	Ended Oct 27, 2023	From the USPTO record
US 10,441,534	Method for treating gynecological diseases Lapsed on the fee record Ended Oct 15, 2023 · From the USPTO record	Lapsed on the fee record	Ended Oct 15, 2023	From the USPTO record
US 10,441,593	Treatment of pain associated with dislocation of endometrium Lapsed on the fee record Ended Oct 15, 2023 · From the USPTO record	Lapsed on the fee record	Ended Oct 15, 2023	From the USPTO record
US 10,172,869	Progesterone receptor modulators for use in the therapy of uterine fibroids Lapsed on the fee record Ended Jan 8, 2023 · From the USPTO record	Lapsed on the fee record	Ended Jan 8, 2023	From the USPTO record
US 8,569,274	Progesterone antagonist and selective progesterone modulator in the treatment of excessive uterine bleeding Lapsed on the fee record Ended Oct 29, 2021 · From the USPTO record	Lapsed on the fee record	Ended Oct 29, 2021	From the USPTO record
US 7,671,027	Use of GnRH agonists to support the luteal phase during infertility treatment Lapsed on the fee record Ended Mar 2, 2018 · From the USPTO record	Lapsed on the fee record	Ended Mar 2, 2018	From the USPTO record
US 7,648,961	Use of somatostatin or one of its analogues for preparing a medicament intended to regulate the ovarian follicular reserve in non-menopausal women Lapsed on the fee record Ended Jan 19, 2018 · From the USPTO record	Lapsed on the fee record	Ended Jan 19, 2018	From the USPTO record